All eyes on ESMO 2019 07 October 2019 - Gerald Kerner MD PhD
This year’s annual European Society for Medical Oncology (ESMO) 2019 Congress took place from 27-30 September. Researchers, clinicians, cancer nurses, industry partners and patient advocates from all over the world gathered down in Barcelona, Spain. With the tagline ‘Translating science into better cancer patient care’, ESMO created the perfect place to exchange knowledge and expertise on the latest advances in oncology. Many practice-changing data were presented, and are summarized in this blog for you.
Continued advances with PD(L)1 inhibitors
Several presentations showed how PD(L)1 inhibitors keep on improving clinical outcomes for several tumor types. One example was the Impower110 trial presented by Dr. David Spigel of the Sarah Cannon Research Institute in Tennessee, analyzing atezolizumab vs platinum-based chemotherapy in first-line treatment of PD-L1 selected NSCLC. The interim results showed... Read more >
| 
